These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1387094)

  • 41. [Clinical significance of and treatment options for increased lipoprotein(a)].
    Zsíros N; Paragh G; Harangi M
    Orv Hetil; 2014 Apr; 155(16):607-14. PubMed ID: 24733102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a).
    Grützmacher P; Öhm B; Szymczak S; Dorbath C; Brzoska M; Kleinert C
    Clin Res Cardiol Suppl; 2017 Mar; 12(Suppl 1):22-26. PubMed ID: 28233269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atherothrombogenicity of lipoprotein(a): the debate.
    Scanu AM
    Am J Cardiol; 1998 Nov; 82(9A):26Q-33Q. PubMed ID: 9819101
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipoprotein(a): from molecules to therapeutics.
    Bermúdez V; Arráiz N; Aparicio D; Rojas E; Gotera D; Guerra X; Canelón R; Faría J; Sorell L; Amell A; Reyna N; Cabrera M; Mengual E; Cano R; Cano C; Velasco M
    Am J Ther; 2010; 17(3):263-73. PubMed ID: 20479580
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Dyslipoproteinemia as a coronary risk factor].
    Yamamura T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():738-45. PubMed ID: 12735059
    [No Abstract]   [Full Text] [Related]  

  • 46. Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
    Boffa MB; Koschinsky ML
    J Lipid Res; 2016 May; 57(5):745-57. PubMed ID: 26647358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipoprotein(a) in health and disease.
    Kronenberg F; Steinmetz A; Kostner GM; Dieplinger H
    Crit Rev Clin Lab Sci; 1996; 33(6):495-543. PubMed ID: 8989507
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Lipoprotein Lp(a) as a risk factor for heart infarct--a family study].
    Klein G; Brugger P; Kullich W; Marth E; Kostner GM
    Wien Med Wochenschr; 1984 Sep; 134(18):403-8. PubMed ID: 6239458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rationale and design of MultiSELECt: A European Multicenter Study on the Effect of Lipoprotein(a) Elimination by lipoprotein apheresis on Cardiovascular outcomes.
    Hohenstein B; Julius U; Lansberg P; Jaeger B; Mellwig KP; Weiss N; Graehlert X; Roeder I; Ramlow W
    Atheroscler Suppl; 2017 Nov; 30():180-186. PubMed ID: 29096835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxidation of lipoprotein Lp(a). A comparison with low-density lipoproteins.
    Sattler W; Kostner GM; Waeg G; Esterbauer H
    Biochim Biophys Acta; 1991 Jan; 1081(1):65-74. PubMed ID: 1825020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process.
    Anglés-Cano E
    Braz J Med Biol Res; 1997 Nov; 30(11):1271-80. PubMed ID: 9532233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipoprotein(a) in health and disease.
    Byrne CD; Wild SH
    Br J Clin Pract; 1994; 48(4):206-11. PubMed ID: 7917801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipoproteins and homocyst(e)ine as risk factors for atherosclerosis: assessment and treatment.
    Frohlich JJ
    Can J Cardiol; 1995 May; 11 Suppl C():18C-23C. PubMed ID: 7750044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lipoprotein(a) - Link between Atherogenesis and Thrombosis.
    Labudovic D; Kostovska I; Tosheska Trajkovska K; Cekovska S; Brezovska Kavrakova J; Topuzovska S
    Prague Med Rep; 2019; 120(2-3):39-51. PubMed ID: 31586503
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Lipoprotein (a). An additional marker of atherosclerosis].
    Mezdour H; Parra HJ; Aguie-Aguie G; Fruchart JC
    Ann Biol Clin (Paris); 1990; 48(3):139-53. PubMed ID: 2141241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heritability of Biomarkers of Oxidized Lipoproteins: Twin Pair Study.
    Rao F; Schork AJ; Maihofer AX; Nievergelt CM; Marcovina SM; Miller ER; Witztum JL; O'Connor DT; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1704-11. PubMed ID: 25953646
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lp(a) and the risk of coronary heart disease.
    Bihari-Varga M; Kostner G; Czinner A
    Eur J Epidemiol; 1992 May; 8 Suppl 1():33-5. PubMed ID: 1387093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Is lipoprotein (a) a link between atherosclerosis and thrombosis?].
    Ehnholm C; Jauhiainen M
    Duodecim; 1990; 106(8):604-7. PubMed ID: 1670247
    [No Abstract]   [Full Text] [Related]  

  • 59. [The pharmacological effects of certain compounds on lipoprotein(a)].
    Monte G; Mezdour H
    Recenti Prog Med; 1993 Dec; 84(12):855-63. PubMed ID: 8108601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Lipoprotein (a) in Alzheimer's atherosclerosis].
    Mooser V
    Rev Med Suisse Romande; 2000 Nov; 120(11):903-6. PubMed ID: 11140310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.